For: | Wei Q, Lee JH, Wu CS, Zang QS, Guo S, Lu HC, Sun Y. Metabolic and inflammatory functions of cannabinoid receptor type 1 are differentially modulated by adiponectin. World J Diabetes 2021; 12(10): 1750-1764 [PMID: 34754376 DOI: 10.4239/wjd.v12.i10.1750] |
---|---|
URL: | https://www.wjgnet.com/1948-9358/full/v12/i10/1750.htm |
Number | Citing Articles |
1 |
Morgan Sotzen, Ahmed Ahmed, L. Karl Olson, Omayma Alshaarawy. Characterization of the effects of cannabinoid receptor deletion on energy metabolism in female C57BL mice. Frontiers in Endocrinology 2024; 15 doi: 10.3389/fendo.2024.1386230
|
2 |
Marija Kurtov, Igor Rubinić, Robert Likić. The endocannabinoid system in appetite regulation and treatment of obesity. Pharmacology Research & Perspectives 2024; 12(5) doi: 10.1002/prp2.70009
|
3 |
Glenn D. Crater, Karine Lalonde, François Ravenelle, Michael Harvey, Jean‐Pierre Després. Effects of CB1R inverse agonist, INV‐202, in patients with features of metabolic syndrome. A randomized, placebo‐controlled, double‐blind phase 1b study. Diabetes, Obesity and Metabolism 2024; 26(2): 642 doi: 10.1111/dom.15353
|